Segment and Geographic Information

9 Months Ended

Feb. 28, 2018

SEGMENT AND GEOGRAPHIC INFORMATION

The Company considers the business to be a single operating segment engaged in the development, manufacture and sale of medical devices for vascular access, peripheral vascular disease, oncology and surgery on a global basis. The Company's chief operating decision maker, the President and Chief Executive Officer (CEO), evaluates the various global product portfolios on a net sales basis. Executives reporting to the CEO include those responsible for commercial operations, manufacturing operations, regulatory and quality and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources.

The table below summarizes net sales by product category:



	Three Months Ended				Nine Months Ended
(in thousands)	Feb 28, 2018		Feb 28, 2017		Feb 28, 2018		Feb 28, 2017
Net sales
Peripheral Vascular	$	48,517	$	48,929	$	149,751	$	154,654
Vascular Access	23,279		23,680		69,091		72,238
Oncology/Surgery	12,055		12,993		37,126		35,837
Total	$	83,851	$	85,602	$	255,968	$	262,729

The table below presents net sales by geographic area based on external customer location (in thousands of dollars):



	Three Months Ended				Nine Months Ended
(in thousands)	Feb 28, 2018		Feb 28, 2017		Feb 28, 2018		Feb 28, 2017
Net sales
United States	$	65,787	$	67,656	$	203,020	$	211,295
International	18,064		17,946		52,948		51,434
Total	$	83,851	$	85,602	$	255,968	$	262,729